{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:16:22Z","timestamp":1791400582672,"version":"4.3.3"},"reference-count":88,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008873","name":"European Society for Paediatric Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cell therapies are an emerging focus for neonatal research, with benefits documented for neonatal respiratory, neurological, and cardiac conditions in pre-clinical studies. Umbilical cord blood (UCB) and umbilical cord (UC) tissue-derived cell therapy is particularly appealing for preventative or regenerative treatment of neonatal morbidities; they are a resource that can be collected at birth and used as an autologous or allogeneic therapy. Moreover, UCB contains a diverse mix of stem and progenitor cells that demonstrate paracrine actions to mitigate damaging inflammatory, immune, oxidative stress, and cell death pathways in several organ systems. In the past decade, published results from early-phase clinical studies have explored the use of these cells as a therapeutic intervention in neonates. We present a systematic review of published and registered clinical trials of UCB and cord tissue-derived cell therapies for neonatal morbidities. This search yielded 12 completed clinical studies: 7 were open-label phase I and II safety and feasibility trials, 3 were open-label dose-escalation trials, 1 was a open-label placebo-controlled trial, and 1 was a phase II randomized controlled trial. Participants totaled 206 infants worldwide; 123 (60%) were full-term infants and 83 (40%) were preterm. A majority (64.5%) received cells via an intravenous route; however, 54 (26.2%) received cells via intratracheal administration, 10 (4.8%) intraoperative cardiac injection, and 9 (4.3%) by direct intraventricular (brain) injection. Assessment of efficacy to date is limited given completed studies have principally been phase I and II safety studies. A further 24 trials investigating UCB and UC-derived cell therapies in neonates are currently registered.<\/jats:p>","DOI":"10.1093\/stcltm\/szab024","type":"journal-article","created":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T04:49:14Z","timestamp":1641012554000},"page":"135-145","source":"Crossref","is-referenced-by-count":40,"title":["Umbilical Cord Blood and Cord Tissue-Derived Cell Therapies for Neonatal Morbidities: Current Status and Future Challenges"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3013-5040","authenticated-orcid":false,"given":"Lindsay","family":"Zhou","sequence":"first","affiliation":[{"name":"The Ritchie Centre, Hudson Institute of Medical Research, Clayton, VIC, Australia"},{"name":"Department of Paediatrics, Monash University, Clayton, VIC, Australia"},{"name":"Monash Children\u2019s Hospital, Monash Health, Clayton, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"McDonald","sequence":"additional","affiliation":[{"name":"The Ritchie Centre, Hudson Institute of Medical Research, Clayton, VIC, Australia"},{"name":"Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Yawno","sequence":"additional","affiliation":[{"name":"The Ritchie Centre, Hudson Institute of Medical Research, Clayton, VIC, Australia"},{"name":"Department of Paediatrics, Monash University, Clayton, VIC, Australia"},{"name":"Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Jenkin","sequence":"additional","affiliation":[{"name":"The Ritchie Centre, Hudson Institute of Medical Research, Clayton, VIC, Australia"},{"name":"Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Miller","sequence":"additional","affiliation":[{"name":"The Ritchie Centre, Hudson Institute of Medical Research, Clayton, VIC, Australia"},{"name":"Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Malhotra","sequence":"additional","affiliation":[{"name":"The Ritchie Centre, Hudson Institute of Medical Research, Clayton, VIC, Australia"},{"name":"Department of Paediatrics, Monash University, Clayton, VIC, Australia"},{"name":"Monash Children\u2019s Hospital, Monash Health, Clayton, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,3,8]]},"reference":[{"key":"2022031715571659200_CIT0001","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/S0140-6736(16)31593-8","article-title":"Global, regional, and national causes of under-5 mortality in 2000-2015: an updated systematic analysis with implications for the Sustainable Development Goals.","volume":"388","author":"Liu","year":"2016","journal-title":"Lancet."},{"key":"2022031715571659200_CIT0002","author":"Chow","year":"2020"},{"issue":"2","key":"2022031715571659200_CIT0003","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jpeds.2013.02.003","article-title":"Long-term neurodevelopmental outcome with hypoxic-ischemic encephalopathy.","volume":"163","author":"Perez","year":"2013","journal-title":"J Paediatr."},{"issue":"6","key":"2022031715571659200_CIT0004","doi-asserted-by":"crossref","first-page":"e20164086","DOI":"10.1542\/peds.2016-4086","article-title":"Changing neurodevelopment at 8 years in children born extremely preterm since the 1990s","volume":"139","author":"Cheong","year":"2017","journal-title":"Pediatrics."},{"issue":"200","key":"2022031715571659200_CIT0005","first-page":"1","article-title":"Perinatal brain injury as a consequence of preterm birth and intrauterine inflammation: designing targeted stem cell therapies.","volume":"11","author":"Paton","year":"2017","journal-title":"Front Neurosci."},{"issue":"200","key":"2022031715571659200_CIT0006","first-page":"1","article-title":"Could cord blood therapy reduce preterm brain injury?","volume":"5","author":"Li","year":"2014","journal-title":"Front Neurol."},{"key":"2022031715571659200_CIT0007","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/pr.2017.236","article-title":"Umbilical cord blood cells for treatment of cerebral palsy: timing and treatment options","volume":"83","author":"McDonald","year":"2017","journal-title":"Pediatr Res."},{"issue":"4","key":"2022031715571659200_CIT0008","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2217\/rme-2018-0171","article-title":"First decade of clinical trials and published studies with mesenchymal stromal cells from umbilical cord tissue","volume":"14","author":"Couto","year":"2019","journal-title":"Regen Med."},{"issue":"1","key":"2022031715571659200_CIT0009","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1634\/stemcells.2007-0381","article-title":"Multipotent stem cells from umbilical cord: cord is richer than blood!","volume":"26","author":"Secco","year":"2008","journal-title":"Stem Cells."},{"issue":"6","key":"2022031715571659200_CIT0010","first-page":"432","article-title":"Transplantation of umbilical cord blood in Fanconi\u2019s anaemia","volume":"32","author":"Gluckman","year":"1990","journal-title":"Nouv Rev Fr Hematol."},{"issue":"5","key":"2022031715571659200_CIT0011","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/sctm.17-0069","article-title":"Umbilical cord blood transplantation: challenges and future directions.","volume":"6","author":"Ballen","year":"2017","journal-title":"Stem Cells Transl Med."},{"key":"2022031715571659200_CIT0012","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/sj.bmt.1700788","article-title":"Umbilical cord blood collection and separation for haematopoietic progenitor cell banking.","volume":"19","author":"Ademokun","year":"1997","journal-title":"Bone Marrow Transplant."},{"key":"2022031715571659200_CIT0013","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/sj.bmt.1702728","article-title":"Collection, processing and cryopreservation of umbilical cord blood for unrelated transplantation.","volume":"26","author":"Reboredo","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"2022031715571659200_CIT0014","doi-asserted-by":"crossref","first-page":"963689721992065","DOI":"10.1177\/0963689721992065","article-title":"Feasibility of umbilical cord blood collection in neonates at risk of brain damage\u2014a step toward autologous cell therapy for a high risk population.","volume":"30","author":"Segler","year":"2021","journal-title":"Cell Transplant."},{"issue":"3","key":"2022031715571659200_CIT0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/14653240510027190","article-title":"Biology of cord blood cells and future prospects of enhanced clinical benefit.","volume":"7","author":"Broxmeyer","year":"2005","journal-title":"Cytotherapy."},{"key":"2022031715571659200_CIT0016","doi-asserted-by":"crossref","first-page":"316","DOI":"10.55782\/ane-2010-1804","article-title":"Umbilical cord blood stem cells\u2014potential therapeutic tool for neural injuries and disorders.","volume":"70","author":"Ali","year":"2010","journal-title":"Acta Neurobiol Exp."},{"issue":"2","key":"2022031715571659200_CIT0017","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1084\/jem.20040440","article-title":"A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential.","volume":"200","author":"Kogler","year":"2004","journal-title":"J Exp Med."},{"key":"2022031715571659200_CIT0018","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2184.2005.00346.x","article-title":"Production of stem cells with embryonic characteristics from human umbilical cord blood.","volume":"38","author":"Mcguckin","year":"2005","journal-title":"Cell Prolif."},{"key":"2022031715571659200_CIT0019","first-page":"194","article-title":"Stem cell therapy to protect and repair the developing brain: a review of mechanisms of action of cord blood and amnion epithelial derived cells.","volume":"7","author":"Castillo-Mendez","year":"2013","journal-title":"Front Neurosci."},{"issue":"47","key":"2022031715571659200_CIT0020","first-page":"1","article-title":"Effects of umbilical cord blood cells, and subtypes, to reduce neuroinflammation following perinatal hypoxic ischaemic brain injury.","volume":"15","author":"McDonald","year":"2018","journal-title":"J Neuroinflammation."},{"key":"2022031715571659200_CIT0021","doi-asserted-by":"crossref","first-page":"114461","DOI":"10.1016\/j.bcp.2021.114461","article-title":"Therapeutic potential of stem cells for preterm brain damage: can we move from the heterogeneity of pre-clinical and clinical studies to established therapeutics?","volume":"186","author":"Passera","year":"2021","journal-title":"Biochem Pharmacol."},{"issue":"7","key":"2022031715571659200_CIT0022","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.exphem.2007.03.019","article-title":"Proliferation differentiation, and cytokine secretion of human umbilical cord blood-derived mononuclear cells in vitro.","volume":"35","author":"Neuhoff","year":"2007","journal-title":"Exp Hematol."},{"key":"2022031715571659200_CIT0023","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3727\/096368911X586783","article-title":"Assessment of neuroprotective effects of human umbilical cord blood mononuclear cell subpopulations in vitro and in vivo.","volume":"21","author":"Boltze","year":"2012","journal-title":"Cell Transplant."},{"issue":"3","key":"2022031715571659200_CIT0024","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1172\/JCI200420622","article-title":"Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model.","volume":"114","author":"Taguchi","year":"2004","journal-title":"J Clin Invest."},{"issue":"3","key":"2022031715571659200_CIT0025","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1165\/rcmb.2013-0385OC","article-title":"Critical role of vascular endothelial growth factor secreted by mesenchymal stem cells in hyperoxic lung injury.","volume":"51","author":"Chang","year":"2014","journal-title":"Am J Respir Cell Mol Biol."},{"issue":"1","key":"2022031715571659200_CIT0026","doi-asserted-by":"crossref","first-page":"L73","DOI":"10.1152\/ajplung.00400.2012","article-title":"Endothelial colony-forming cell conditioned media promote angiogenesis in vitro and prevent pulmonary hypertension in experimental bronchopulmonary dysplasia.","volume":"305","author":"Baker","year":"2013","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"issue":"1","key":"2022031715571659200_CIT0027","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jss.2013.05.073","article-title":"Transplantation of expanded endothelial colony-forming cells improved outcomes of traumatic brain injury in a mouse model.","volume":"185","author":"Zhang","year":"2013","journal-title":"J Surg Res."},{"key":"2022031715571659200_CIT0028","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.mvr.2010.01.012","article-title":"Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation.","volume":"79","author":"Tongers","year":"2010","journal-title":"Microvasc Res."},{"issue":"11","key":"2022031715571659200_CIT0029","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/sctm.19-0082","article-title":"Human cord blood-derived unrestricted somatic stem cell infusion improves neurobehavioral outcome in a rabbit model of intraventricular hemorrhage.","volume":"8","author":"Vinukonda","year":"2019","journal-title":"Stem Cells Transl Med."},{"key":"2022031715571659200_CIT0030","doi-asserted-by":"crossref","first-page":"633185","DOI":"10.3389\/fncel.2021.633185","article-title":"Human cord blood derived unrestricted somatic stem cells restore aquaporin channel expression, reduce inflammation and inhibit the development of hydrocephalus after experimentally induced perinatal intraventricular hemorrhage.","volume":"15","author":"Purohit","year":"2021","journal-title":"Front Cell Neurosci."},{"issue":"9","key":"2022031715571659200_CIT0031","doi-asserted-by":"crossref","first-page":"e0138680","DOI":"10.1371\/journal.pone.0138680","article-title":"Preterm cord blood contains a higher proportion of immature hematopoietic progenitors compared to term samples.","volume":"10","author":"Podesta","year":"2015","journal-title":"PLoS One."},{"issue":"9","key":"2022031715571659200_CIT0032","doi-asserted-by":"crossref","first-page":"e106717","DOI":"10.1371\/journal.pone.0106717","article-title":"Hematopoietic stem cells in neonates: any difference between very preterm and term neonates?","volume":"9","author":"Wisgrill","year":"2014","journal-title":"PLoS One."},{"key":"2022031715571659200_CIT0033","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fmed.2017.00061","article-title":"The future of bronchopulmonary dysplasia: emerging pathophysiological concepts and potential new avenues of treatment.","volume":"4","author":"Collins","year":"2017","journal-title":"Front Med."},{"issue":"11","key":"2022031715571659200_CIT0034","doi-asserted-by":"crossref","first-page":"e1914611","DOI":"10.1001\/jamanetworkopen.2019.14611","article-title":"Association of chorioamnionitis with bronchopulmonary dysplasia among preterm infants: a systematic review, meta-analysis and metaregression.","volume":"2","author":"Villamor-Martinez","year":"2019","journal-title":"JAMA Netw Open."},{"key":"2022031715571659200_CIT0035","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.rmed.2017.10.014","article-title":"Bronchopulmonary dysplasia: a review of pathogenesis and pathophysiology.","volume":"132","author":"Thekkeveedu","year":"2017","journal-title":"Respir Med."},{"issue":"10","key":"2022031715571659200_CIT0036","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1164\/rccm.200611-1660PP","article-title":"Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease.","volume":"175","author":"Thebaud","year":"2007","journal-title":"Am J Respir Crit Care Med."},{"issue":"5","key":"2022031715571659200_CIT0037","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jpeds.2013.12.011","article-title":"Mesenchymal stem cells for bronchopulmonary dysplasia: a phase 1 dose-escalation trial.","volume":"164","author":"Chang","year":"2014","journal-title":"J Pediatr."},{"key":"2022031715571659200_CIT0038","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jpeds.2019.02.029","article-title":"Safety of intratracheal administration of human umbilical cord derived mesenchymal stromal cells in extremely low birth weight preterm infants.","volume":"210","author":"Powell","year":"2019","journal-title":"J Pediatr."},{"issue":"8","key":"2022031715571659200_CIT0039","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/sctm.20-0330","article-title":"Stem cells for bronchopulmonary dysplasia in preterm infants: a randomised controlled phase II trial.","volume":"10","author":"Anh","year":"2021","journal-title":"Stem Cells Transl Med."},{"issue":"2","key":"2022031715571659200_CIT0040","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/sctm.19-0106","article-title":"Autologous cord blood cell infusion in preterm neonates safely reduces respiratory support duration and potentially preterm complications.","volume":"9","author":"Ren","year":"2019","journal-title":"Stem Cells Transl Med."},{"key":"2022031715571659200_CIT0041","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3727\/096368909X471189","article-title":"Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats.","volume":"18","author":"Chang","year":"2009","journal-title":"Cell Transplant."},{"issue":"3","key":"2022031715571659200_CIT0042","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1165\/rcmb.2013-0385OC","article-title":"Critical role of vascular endothelial growth factor secreted by mesenchymal stem cells in hyperoxic lung injury.","volume":"51","author":"Chang","year":"2014","journal-title":"Am J Respir Cell Mol Biol."},{"issue":"12","key":"2022031715571659200_CIT0043","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/sctm.17-0126","article-title":"Mesenchymal stromal cell therapy in bronchopulmonary dysplasia: systematic review and meta-analysis of preclinical studies.","volume":"6","author":"Augustine","year":"2017","journal-title":"Stem Cells Transl Med."},{"key":"2022031715571659200_CIT0044","doi-asserted-by":"crossref","first-page":"615508","DOI":"10.3389\/fped.2021.615508","article-title":"A review of placenta and umbilical cord-derived stem cells and the immunomodulatory basis of their therapeutic potential in bronchopulmonary dysplasia.","volume":"9","author":"Chia","year":"2021","journal-title":"Front Pediatr."},{"issue":"3","key":"2022031715571659200_CIT0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S2352-4642(19)30402-X","article-title":"Global, regional and national burden of congenital heart disease 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"4","author":"Zimmerman","year":"2020","journal-title":"Lancet Child Adolesc Health."},{"issue":"8","key":"2022031715571659200_CIT0046","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/CIR.0000000000000352","article-title":"Chronic heart failure in congenital heart disease\u2014a scientific statement from the American Heart Association.","volume":"133","author":"Stout","year":"2016","journal-title":"Circulation."},{"issue":"1-2","key":"2022031715571659200_CIT0047","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/pr.2016.194","article-title":"Hypoplastic left heart syndrome: from comfort care to long-term survival.","volume":"81","author":"Yabrodi","year":"2017","journal-title":"Pediatr Res."},{"issue":"24","key":"2022031715571659200_CIT0048","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1161\/CIRCULATIONAHA.117.029607","article-title":"Stem cell therapy for congenital heart disease: a systematic review.","volume":"136","author":"Tsilimigras","year":"2017","journal-title":"Circulation."},{"issue":"6","key":"2022031715571659200_CIT0049","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.jtcvs.2019.06.001","article-title":"Autologous stem cell therapy for hypoplastic left heart syndrome: safety and feasibility of intraoperative intramyocardial injections.","volume":"158","author":"Burkhart","year":"2019","journal-title":"J Thorac Cardiovasc Surg."},{"issue":"3","key":"2022031715571659200_CIT0050","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1053\/j.semtcvs.2020.11.002","article-title":"Clinical impact of autologous cell therapy on hypoplastic left heart syndrome after bidirectional cavopulmonary anastomosis.","volume":"33","author":"Vincenti","year":"2020","journal-title":"Semin Thorac Cardiovasc Surg."},{"issue":"1","key":"2022031715571659200_CIT0051","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cardiores.2004.12.013","article-title":"Human cord blood cells induce angiogenesis following myocardial infarction in NOD\/scid-mice.","volume":"66","author":"Ma","year":"2005","journal-title":"Cardiovasc Res."},{"issue":"18","key":"2022031715571659200_CIT0052","first-page":"1","article-title":"Intramuscular injection of human umbilical cord blood-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy mice.","volume":"8","author":"Mao","year":"2017","journal-title":"Stem Cell Res Ther."},{"issue":"2","key":"2022031715571659200_CIT0053","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.athoracsur.2009.10.035","article-title":"Human cord blood stem cells enhance neonatal right ventricular function in an ovine model of right ventricular training.","volume":"89","author":"Davies","year":"2010","journal-title":"Ann Thorac Surg."},{"issue":"8","key":"2022031715571659200_CIT0054","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3727\/096368909X471170","article-title":"Autologous umbilical cord blood mononuclear cell transplantation preserves right ventricular function in a novel model of chronic right ventricular volume overload.","volume":"18","author":"Yerebakan","year":"2009","journal-title":"Cell Transplant."},{"key":"2022031715571659200_CIT0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-981-10-1412-3_3","article-title":"Pathophysiology and pathology of neonatal hypoxic ischaemic encephalopathy.","volume-title":"Cell Therapy for Perinatal Brain Injury","author":"Hayakawa","year":"2018"},{"key":"2022031715571659200_CIT0056","first-page":"CD001133","article-title":"Cooling for newborns with hypoxic ischaemic encephalopathy.","volume":"1","author":"Jacobs","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"key":"2022031715571659200_CIT0057","doi-asserted-by":"crossref","first-page":"F220","DOI":"10.1136\/adc.2008.148205","article-title":"Long term outcome after neonatal hypoxic ischaemic encephalopathy.","volume":"95","author":"de Vries","year":"2010","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"issue":"12","key":"2022031715571659200_CIT0058","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S2352-4642(18)30287-6","article-title":"Changes in long-term prognosis with increasing postnatal survival and the occurrence of postnatal morbidities in extremely preterm infants offered intensive care: a prospective observational study.","volume":"2","author":"Cheong","year":"2018","journal-title":"Lancet Child Adolesc Health."},{"key":"2022031715571659200_CIT0059","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.resuscitation.2021.02.014","article-title":"European Resuscitation Council Guidelines 2021: newborn resuscitation and support of transition of infants at birth.","volume":"161","author":"Mader","year":"2021","journal-title":"Resuscitation."},{"issue":"5","key":"2022031715571659200_CIT0060","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jpeds.2013.11.036","article-title":"Feasibility of autologous cord blood cells for infants with hypoxic ischaemic encephalopathy.","volume":"164","author":"Cotten","year":"2014","journal-title":"J Pediatr."},{"issue":"1","key":"2022031715571659200_CIT0061","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1038\/s41598-020-61311-9","article-title":"Autologous cord blood cell therapy for neonatal hypoxic ischaemic encephalopathy: a pilot study for feasibility and safety.","volume":"10","author":"Tsuji","year":"2020","journal-title":"Sci Rep."},{"issue":"1","key":"2022031715571659200_CIT0062","doi-asserted-by":"crossref","first-page":"27","DOI":"10.22494\/COT.V1I1.45","article-title":"Autologous umbilical cord blood cells for newborn infants with hypoxic ishchaemic encephalopathy.","volume":"1","author":"Jiun","year":"2013","journal-title":"Cell Organ Transplantol."},{"issue":"5","key":"2022031715571659200_CIT0063","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.1016\/j.jcyt.2020.04.052","article-title":"Phase 1 trial of allogeneic umbilical cord tissue-derived mesenchymal stromal cells in neonates with hypoxic ischaemic encephalopathy.","volume":"22","author":"Cotten","year":"2020","journal-title":"Cytotherapy."},{"issue":"12","key":"2022031715571659200_CIT0064","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/sctm.17-0219","article-title":"Mesenchymal stem cells for severe intraventricular haemorrhage in preterm infants: phase 1 dose-escalation clinical trial.","volume":"7","author":"Anh","year":"2018","journal-title":"Stem Cells Transl Med."},{"key":"2022031715571659200_CIT0065","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/pr.2015.161","article-title":"Repeated autologous umbilical cord blood infusions are feasible and had no acute safety issues in young babies with congenital hydrocephalus.","volume":"78","author":"Sun","year":"2015","journal-title":"Pediatr Res."},{"issue":"2","key":"2022031715571659200_CIT0066","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000368396","article-title":"Administration of umbilical cord blood cells transiently decreased hypoxic-ischemic brain injury in neonatal rats.","volume":"37","author":"Hattori","year":"2015","journal-title":"Dev Neurosci."},{"issue":"4-5","key":"2022031715571659200_CIT0067","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000374107","article-title":"Human umbilical cord blood cells ameliorate motor deficits in rabbits in a cerebral palsy model.","volume":"37","author":"Drobyshevky","year":"2015","journal-title":"Dev Neurosci."},{"issue":"5","key":"2022031715571659200_CIT0068","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1113\/JP271104","article-title":"Cord blood mononuclear cells prevent neuronal apoptosis in response to perinatal asphyxia in the newborn lamb.","volume":"594","author":"Aridas","year":"2016","journal-title":"J Physiol."},{"key":"2022031715571659200_CIT0069","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.expneurol.2018.07.006","article-title":"Preterm umbilical cord derived mesenchymal stem\/stromal cells protect preterm white matter brain development against hypoxia-ischemia.","volume":"308","author":"Li","year":"2018","journal-title":"Exp Neurol."},{"key":"2022031715571659200_CIT0070","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/STROKEAHA.112.679092","article-title":"Mesenchymal stem cells prevent hydrocephalus after severe intraventricular hemorrhage.","volume":"44","author":"Ahn","year":"2013","journal-title":"Stroke."},{"key":"2022031715571659200_CIT0071","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/pr.2012.71","article-title":"Human umbilical cord derived mesenchymal stem cell transplantation attenuates severe brain injury by permanent middle cerebral artery occlusion in newborn rats.","volume":"72","author":"Kim","year":"2012","journal-title":"Pediatr Res."},{"issue":"3","key":"2022031715571659200_CIT0072","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000490943","article-title":"Human umbilical cord blood therapy protects cerebral white matter from systemic LPS exposure in preterm fetal sheep.","volume":"40","author":"Paton","year":"2018","journal-title":"Dev Neurosci."},{"issue":"2","key":"2022031715571659200_CIT0073","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41390-019-0366-z","article-title":"Umbilical cord blood versus mesenchymal stem cells for inflammation induced preterm brain injury in fetal sheep.","volume":"86","author":"Paton","year":"2019","journal-title":"Pediatr Res."},{"key":"2022031715571659200_CIT0074","doi-asserted-by":"crossref","first-page":"e036065","DOI":"10.1136\/bmjopen-2019-036065","article-title":"Autologous transplantation of umbilical cord blood-derived cells in extreme preterm infants: protocol for a safety and feasibility study.","volume":"10","author":"Malhotra","year":"2020","journal-title":"BMJ Open."},{"issue":"12","key":"2022031715571659200_CIT0075","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/sctm.17-0102","article-title":"Effect of autologous cord blood infusion on motor function and brain connectivity in young children with cerebral palsy: a randomised, placebo-controlled trial.","volume":"6","author":"Sun","year":"2017","journal-title":"Stem Cells Transl Med."},{"key":"2022031715571659200_CIT0076","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/stem.1304","article-title":"Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomised, placebo-controlled trial.","volume":"31","author":"Min","year":"2013","journal-title":"Stem Cells."},{"key":"2022031715571659200_CIT0077","doi-asserted-by":"crossref","first-page":"e0349743","DOI":"10.1136\/bmjopen-2019-034974","article-title":"Single group multisite safety trial of sibling cord blood cell infusion to children with cerebral palsy: study protocol and rationale.","volume":"10","author":"Crompton","year":"2020","journal-title":"BMJ Open."},{"issue":"1","key":"2022031715571659200_CIT0078","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jcyt.2021.07.001","article-title":"Safety of allogeneic umbilical cord blood infusions for the treatment of neurological conditions: a systematic review of clinical studies.","volume":"24","author":"Paton","journal-title":"Cytotherapy."},{"issue":"2","key":"2022031715571659200_CIT0079","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1537-2995.1996.36296181922.x","article-title":"Post transfusion graft-vs-host disease in Japanese newborns.","volume":"36","author":"Ohto","year":"1996","journal-title":"Transfusion."},{"issue":"6","key":"2022031715571659200_CIT0080","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3109\/14767058.2014.928859","article-title":"Transfusion-associated graft versus host disease (TAGVHD)\u2014with reference to the neonatal period.","volume":"28","author":"Gokhale","year":"2015","journal-title":"J Matern Fetal Neonatal Med."},{"key":"2022031715571659200_CIT0081","first-page":"1","article-title":"An effective ex-vivo approach for inducing endothelial progenitor cells from umbilical cord blood CD34+ cells.","volume":"25","author":"Qin","year":"2017","journal-title":"Stem Cell Res Ther."},{"issue":"20","key":"2022031715571659200_CIT0082","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1089\/scd.2016.0153","article-title":"Impact of oxygen levels on human hematopoietic stem and progenitor cell expansion.","volume":"25","author":"Tiwari","year":"2016","journal-title":"Stem Cells Dev."},{"key":"2022031715571659200_CIT0083","doi-asserted-by":"crossref","first-page":"2A.11.1","DOI":"10.1002\/cpsc.42","article-title":"Controlling the effective oxygen tension experienced by cells using a dynamic culture technique for hematopoietic ex vivo expansion.","volume":"44","author":"Tiwari","year":"2018","journal-title":"Curr Protoc Stem Cell Biol."},{"issue":"2","key":"2022031715571659200_CIT0084","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1016\/S2352-3026(19)30202-9","article-title":"Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.","volume":"7","author":"Cohen","year":"2020","journal-title":"Lancet Haematol."},{"key":"2022031715571659200_CIT0085","doi-asserted-by":"crossref","first-page":"9847015","DOI":"10.1155\/2018\/9847015","article-title":"Insights into endothelial progenitor cells: origin, classification, potentials and prospects.","volume":"2018","author":"Chopra","year":"2018","journal-title":"Stem Cells Int."},{"key":"2022031715571659200_CIT0086","doi-asserted-by":"crossref","first-page":"530","DOI":"10.5966\/sctm.2015-0227","article-title":"Concise review: endothelial progenitor cells in regenerative medicine: applications and challenges.","volume":"5","author":"Chong","year":"2016","journal-title":"Stem Cells Transl Med."},{"issue":"Pt A","key":"2022031715571659200_CIT0087","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.expneurol.2016.06.017","article-title":"Preterm white matter brain injury is prevented by early administration of umbilical cord blood cells.","volume":"283","author":"Li","year":"2016","journal-title":"Exp Neurol."},{"key":"2022031715571659200_CIT0088","doi-asserted-by":"crossref","first-page":"147001","DOI":"10.1016\/j.brainres.2020.147001","article-title":"Multiple doses of umbilical cord blood cells improve long-term brain injury in the neonatal rat.","volume":"1746","author":"Penny","year":"2020","journal-title":"Brain Res."}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/11\/2\/135\/42947150\/szab024.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/11\/2\/135\/42947150\/szab024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T13:51:53Z","timestamp":1726408313000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/11\/2\/135\/6544714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":88,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,3,8]]},"published-print":{"date-parts":[[2022,3,17]]}},"URL":"https:\/\/doi.org\/10.1093\/stcltm\/szab024","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,1]]},"published":{"date-parts":[[2022,2,1]]}}}